English

Tekbiotech-Yeast and Phage Display CRO, Expert in Nano-body and Antibody Drug Development

Anti-HSP91 Homolog重组抗体|科研级 Efungumab ( 依芬古单抗 )

询价与订购

  • Name*

  • Phone*

  • Email*

  • Product*

  • Content*

Anti-HSP91 Homolog重组抗体|科研级 Efungumab ( 依芬古单抗 )

CatNo:TKYR1109

  • 1mg
  • 5mg
WeChat QR
Contact Us
instructions
MSDS
WeChat QR
Contact Us
  • Detailed
  • Background
  • Plan&FAQ
  • Related
  • Recommended
  • Detailed related information

    Catalog Number

    TKYR1109

    Alias

    科研级 Efungumab ( 依芬古单抗 ), Anti-HSP91 Homolog Recombinant Antibody, Research Grade Efungumab

    Molecular Name

    Efungumab

    Size

    1mg, 5mg

    CAS Number

    762260-74-2

    Isotype

    scFv-heavy Kappa

    Clonality

    Monoclonal

    Concentration

    1mg/ml

    Applications

    FC, IP, ELISA, Neut, FuncS, IF, WB

    Source

    CHO Cells

    Purity

    ≥95% as determined by SDS-PAGE

    Buffer

    Supplied in PBS, PH7.5

    Target

    HSP91 homolog[Candida albicans]

    Sequence

    Please contact our sales representative to learn more information about this reagents.

    Background

    Efungumab (trade name Mycograb) was a drug developed by NeuTec Pharma (a subsidiary of Novartis), intended to treat candidemia (a bloodstream infection caused by pathogenic yeast) in combination with amphotericin B. The European Medicines Agency has twice refused to grant marketing authorization for Mycograb, citing product safety and quality issues.

    Storage

    该产品可在 2°C-8°C 下保存一个月,活性不会明显降低。在 -20°C 至 -80°C 下保存,可稳定保存十二个月。避免反复冻融,用冰袋运输。

    NOTE

    仅科研使用
    Target background information
    Experimental Plan&FAQ

    To experience the reliable service of Tekbiotech please subscribe: